Tue, Oct 21, 2014, 6:23 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • labois4u labois4u Jul 18, 2013 9:29 AM Flag

    Fud: What is your agenda? And why does...

    ...it not fit Mr Lewis his agenda? Do you know his agenda?

    Be transparent and maybe Mr Lewis will adjust his to yours!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • fudfighter4 doesn't have an agenda... she is just that nutty. Taunts to her and other no-nuthins used to say "Call the SEC!"........ LOL,...which is of course is laughable. Insmed did well by shareholders, Institutions and Wall street at large. No doubt Will Lewis, a former hedge fund manager know who controls what power.
      After the Russell funds absorbed many shares,the company dealt with Wall Street banker's and Institutions
      To say, analysts ( who have a brokerage interest and their own interest only) would have a say in the value of the offering is...of course again laughable....A bank takes a risk buying shares and if NTM fails and the FDA asks for a CF trial in the U.S,this stock will be nowhere near 9.78 a share.
      As I posted earlier this provides liquidity and allows those that took a risk to make back their investment with minimal risk (by terry_insm • 21 hours ago "These guys just don't make money once....-)
      Even with the ignore on ,Evelyn gets response ..amazin...simpy amazin ...

      • 5 Replies to terry_insm
      • terry_insm • Jul 18, 2013 1:39 PM .

        fudfighter4 doesn't have an agenda... she is just that nutty. Taunts to her and other no-nuthins used to say "Call the SEC!"........ LOL,...which is of course is laughable. Insmed did well by shareholders, Institutions and Wall street at large. No doubt Will Lewis, a former hedge fund manager know who controls what power.
        After the Russell funds absorbed many shares,the company dealt with Wall Street banker's and Institutions
        To say, analysts ( who have a brokerage interest and their own interest only) would have a say in the value of the offering is...of course again laughable....A bank takes a risk buying shares and if NTM fails and the FDA asks for a CF trial in the U.S,this stock will be nowhere near 9.78 a share.
        As I posted earlier this provides liquidity and allows those that took a risk to make back their investment with minimal risk (by terry_insm • 21 hours ago "These guys just don't make money once....-)
        Even with the ignore on ,Evelyn gets response ..amazin...simpy amazin ...

      • You still here? Too funny.

      • Thanks kevie for all the thumbs!
        fudfighter4 doesn't have an agenda... she is just that nutty. Taunts to her and other no-nuthins used to say "Call the SEC!"........ LOL,...which is of course is laughable. Insmed did well by shareholders, Institutions and Wall street at large. No doubt Will Lewis, a former hedge fund manager know who controls what power.
        After the Russell funds absorbed many shares,the company dealt with Wall Street banker's and Institutions
        To say, analysts ( who have a brokerage interest and their own interest only) would have a say in the value of the offering is...of course again laughable....A bank takes a risk buying shares and if NTM fails and the FDA asks for a CF trial in the U.S,this stock will be nowhere near 9.78 a share.
        As I posted earlier this provides liquidity and allows those that took a risk to make back their investment with minimal risk (by terry_insm • 21 hours ago "These guys just don't make money once....-)
        Even with the ignore on ,Evelyn gets response ..amazin...simpy amazin ...

      • you dat smar test guy in da room witch aint sayin mouch. willie get da money utterwise da wall guys spank him very hard!.Brokerrs make me broker. He say sell dat stack!

      • Terry. You must have a fantasy "Ignore" button, or else it doesn't work. How many times have you put the same people on "Ignore" but still respond anyway. No credibility on your part.

    • My current agenda is a SEC investigation into the sequence of events which culminated in the Company issuing shares AFTER the Phase III success which valued the Company at 51% of the average analyst valuation BEFORE Phase III success.

 
INSM
13.63+0.11(+0.81%)Oct 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.